Connector

NCATS Trial Innovation Network (TIN)

Harvard Catalyst is a member of the Trial Innovation Network (TIN). The TIN, funded by the National Center for Advancing Translational Sciences (NCATS) at NIH, is a collaborative national network of all CTSA Program Hubs for facilitating faster and more cost-effective multisite studies, including use of a single IRB system and master contracting agreements.

NCATS is committed to removing roadblocks to clinical research by identifying and sharing best practice in clinical and translational research. The TIN includes two Trial Innovation Centers (TICs), which focus on operational excellence and a Recruitment Innovation Center (RIC), which focuses on developing evidence-based recruitment and retention methods as well as guidance for working with the community. The TIN also offers a toolbox of resources. Harvard investigators can propose studies to the TIN or become a site investigator for an external study shared with Harvard through the TIN. Opportunities to become a site investigator come from the TIN to our local TIN liaisons who will then forward the opportunity to researchers working in relevant areas.

For Harvard investigators wishing to initiate their own study through the TIN:

Proposals submitted to the TIN must be accompanied by a letter of support from Harvard Catalyst. Your local TIN Liaison can support you through the proposal submission process. If your proposal is selected by the TIN to move forward, your TIN Liaison and their team can help you get your study up and running, and connect you with other needed resources. For more information, see the Proposal Submission Instructions on the TIN website.